K
Karla V. Ballman
Researcher at Cornell University
Publications - 390
Citations - 34158
Karla V. Ballman is an academic researcher from Cornell University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 78, co-authored 353 publications receiving 29127 citations. Previous affiliations of Karla V. Ballman include University of South Florida & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.
Jennifer A. Ligibel,Karla V. Ballman,Linda M. McCall,Pamela J. Goodwin,Anna Weiss,Linda M. Delahanty,Catherine M. Alfano,Tracy E. Crane,Marian L. Neuhouser,Patricia A. Spears,Dawn L. Hershman,Electra D. Paskett,Judith O. Hopkins,Vanessa Bernstein,Vered Stearns,Thomas A. Wadden,Eric P. Winer,Ann H. Partridge,Lisa A. Carey +18 more
TL;DR: The Breast Cancer Weight Loss (BWEL) trial as discussed by the authors evaluated the impact of a WLI on invasive disease-free survival in breast cancer patients (pts) with a body mass index (BMI) ³27 kg/m2.
Proceedings ArticleDOI
Integrative Analysis of Extracellular Lipocalin-2 and the Lung Microbiome in Smoking and COPD
Cé ine Healy,Colin Campbell,Katherine Hoffman,James J. Butler,Kristopher Opron,John R. Erb-Downward,W.Z. Zhang,Igor Barjaktarevic,M. Han,Robert J. Kaner,Jeffrey L. Curtis,R. Graham Barr,Alejandro P. Comellas,Claire M. Doerschuk,Nirupama Putcha,Wendy C. Moore,James A. Wells,Sarah L. O’Beirne,Gerard J. Criner,Christopher B. Cooper,Sanjeev M. Raman,Annette T. Hastie,R. Paine,N. Hansel,P.G. Woodruff,Russell P. Bowler,Karla V. Ballman,Gary B. Huffnagle,Francisco Martínez,Y.J. Huang,Imran Sulaiman,Suzanne M. Cloonan,Spiromics +32 more
Journal ArticleDOI
Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).
Daniel G. Stover,Roberto Salgado,Oleksandr Savenkov,Karla V. Ballman,Mark Jesus M. Magbanua,Sherene Loi,Erica L. Mayer,Mark Vater,Mark A. Watson,Yujia Wen,W. Fraser Symmans,Charles M. Perou,Lisa A. Carey,Ann H. Partridge,Hope S. Rugo +14 more
TL;DR: In this paper , the authors evaluated the association of sTIL quantity with survival outcome in the metastatic (met) setting without checkpoint blockade in the CALGB (Alliance) 40502 trial.
Journal ArticleDOI
Radiation therapy and irreversible electroporation for intermediate risk prostate cancer (RTIRE).
Timothy D. McClure,Karla V. Ballman,Ariel E. Marciscano,Christopher E. Barbieri,Himanshu Nagar +4 more
TL;DR: The RTIRE clinical trial as mentioned in this paper evaluated the feasibility, safety, and early oncologic efficacy of combining MRI-guided stereotactic body radiation therapy (MRgSBRT) with irreversible electroporation (IRE) for men with intermediate risk localized prostate cancer.